Safety evaluation of a novel progesterone vaginal ring (PVR) for luteal phase support: SARA trial

Medical Journal
Written by Jacqui Behler

Stadtmauer LA, Schnell VL, Park JK, Slater CC, Foster ED, Grover SA, Heiser PW. Safety evaluation of a novel progesterone vaginal ring (PVR) for luteal phase support: SARA trial. Drug Deliv Transl Res. 2026 May 29. doi: 10.1007/s13346-026-02158-x. Epub ahead of print. PMID: 42213348.

Jacqui Behler
Previous

Conjoined ischiopagus twins after single euploid embryo transfer: A case report and review of the literature
Next

Clinical embryology in the United States: current landscape and considerations for professional development and standardization